short term upside in july

Some drivers to watch for:

1. Litigation settlement talks due in July;
2. Phase II LANI due in coming weeks (fast recruitment seen from commencement of trial on 22/11/2007 and completed on 7/4, 11/2 at two trial sites);
3. Upside from positive news on Relenza, e.g. Sales orders from USA or Japan;
4. End of FY tax loss selling will stop;
5. Quarterly sales of Relenza due.

Certainly not the average boring biotech! It has the right product, right pipeline, right balance sheet and right blue sky at the right time!

Go Biota!!!